0001766784-19-000001.txt : 20190206 0001766784-19-000001.hdr.sgml : 20190206 20190206160652 ACCESSION NUMBER: 0001766784-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190206 DATE AS OF CHANGE: 20190206 EFFECTIVENESS DATE: 20190206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mediar Therapeutics, Inc. CENTRAL INDEX KEY: 0001766784 IRS NUMBER: 832874878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-332291 FILM NUMBER: 19571619 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02124 BUSINESS PHONE: 617-954-9356 MAIL ADDRESS: STREET 1: 215 FIRST STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02124 D 1 primary_doc.xml X0708 D LIVE 0001766784 Mediar Therapeutics, Inc. 215 FIRST STREET, SUITE 500 CAMBRIDGE MA MASSACHUSETTS 02124 617-954-9356 DELAWARE None None Corporation true 2018 Stacey Brenner 215 First Street Suite 500 Cambridge MA MASSACHUSETTS 02142 Executive Officer Meredith Fisher 215 First Street Suite 500 Cambridge MA MASSACHUSETTS 02142 Director Brian Hubbard 215 First Street Suite 500 Cambridge MA MASSACHUSETTS 02142 Director Peter Parker 215 First Street Suite 500 Cambridge MA MASSACHUSETTS 02142 Director David de Graaf 215 First Street Suite 500 Cambridge MA MASSACHUSETTS 02142 Director Other Decline to Disclose 06b false 2019-01-29 false true false 0 10000000 5000000 5000000 false 7 0 0 0 false Mediar Therapeutics, Inc. /s/ Stacey Brenner Stacey Brenner Chief Executive Officer 2019-02-06